Steve Sweet
stevemsweet.bsky.social
Steve Sweet
@stevemsweet.bsky.social
Scientist working in the field of clinical proteomics.
https://scholar.google.com/citations?user=jQ_KiOEAAAAJ&hl=en
Reposted by Steve Sweet
My lab @stanfordmedicine.bsky.social is recruiting! We are looking for a postdoc at the interface of quantitative proteomics and G protein-coupled receptor (GPCR) biology:
postdocs.stanford.edu/prospective/...
#TeamMassSpec #Proteomics #GPCR #Postdoc
Open Postdoctoral position, faculty mentor Ruth Huttenhain | Office of Postdoctoral Affairs
postdocs.stanford.edu
October 2, 2025 at 6:27 PM
Reposted by Steve Sweet
Sarafan ChEM-H awards four $25K seed grants to fund collaborations w/ the new chemoproteomics group, led by @dina-sch.bsky.social at the Nucleus, a collection of labs that leverage scientific experts& advanced instrumentation to facilitate discoveries @stanford.edu chemh.stanford.edu/news/sarafan...
Sarafan ChEM-H awards four $25K seed grants to fund collaborations with the new chemoproteomics group at the Nucleus
The grants will give researchers access to advanced instrumentation and technical guidance for a variety of specialized proteomics techniques.
chemh.stanford.edu
September 24, 2025 at 5:06 PM
Reposted by Steve Sweet
We are looking for visionary scientists ready to establish an independent, world-leading research programme & take full advantage of the extraordinary collaborative ecosystem including @mcrcnews.bsky.social @manchester.ac.uk, The Christie NHS Foundation Trust & @cruknbc.bsky.social

#OncoSky
New Group Leader Recruitment Now Open (MI/25/54) | Cancer Research UK Manchester Institute
We are seeking to appoint exceptional early-career scientists, including clinician scientists, as Group Leaders to develop bold, innovative, and high-impact research programmes.
www.cruk.manchester.ac.uk
September 24, 2025 at 3:03 PM
🔬 Excited for ASMS 2025? Join AstraZeneca's Translational Proteomics group to explore cutting-edge topics in clinical proteomics! Check out our innovative work in cancer research and MS methodologies, applied to FFPE samples.
#ASMS2025 #Proteomics #CancerResearch #AstraZeneca
tinyurl.com/25bpkzhz
#asms2025 #proteomics #cancerresearch #astrazeneca | Steve Sweet
🔬 Excited for ASMS 2025? Join AstraZeneca's Translational Proteomics research group to explore cutting-edge topics in clinical proteomics! Check out our posters for innovative approaches in cancer...
www.linkedin.com
May 30, 2025 at 8:27 PM
Reposted by Steve Sweet
Our Translational Proteomics team is recruiting a Senior Scientist!
We're based in Gaithersburg, MD, USA.
A great opportunity to apply your skills to clinical trial samples, helping to develop new oncology drugs.
Please share!
astrazeneca.wd3.myworkdayjobs.com/Careers/job/...
Senior Scientist, Translational Proteomics, Global Mass Spectrometry
Senior Scientist, Translational Proteomics, Mass Spectrometry Introduction to role Do you have a passion for Translational Proteomics and Mass Spectrometry? We are looking for a bold scientist to impa...
astrazeneca.wd3.myworkdayjobs.com
March 18, 2025 at 1:20 PM
Reposted by Steve Sweet
This blog by Stuart Macdonald, visiting professor at the University of Leicester is worth a read.

In this context it would be interesting to see how REF 4* publications correlate to metrics.

My guess is that for Archaeology, not much.
Does authorship mean anything when academic papers are simply citable tokens?
The bibliometric infrastructure of citations has become an inescapable organising feature of academic life. Drawing on a range of evidence of the use and misuse of citations data, Stuart Macdonald …
blogs.lse.ac.uk
February 18, 2025 at 12:56 PM
This piece from Rafael Irizarry gives a nice overview of UMAP, complete with convenient example R code.

simplystatistics.org/posts/2024-1...
Simply Statistics: Biologists, stop putting UMAP plots in your papers
UMAP is a powerful tool for exploratory data analysis, but without a clear understanding of how it works, it can easily lead to confusion and misinterpretation.
simplystatistics.org
December 23, 2024 at 5:00 PM